Skip to main content
Download PDF

Treatment with Rhodiola crenulata root extract ameliorates insulin resistance in fructose-fed rats by modulating sarcolemmal and intracellular fatty acid translocase/CD36 redistribution in skeletal muscle

BMC Complementary and Alternative Medicine volume 16, Article number: 209 (2016) Cite this article

Abstract

Background

Rhodiola species have been used for asthenia, depression, fatigue, poor work performance and cardiovascular diseases, all of which may be associated with insulin resistance. To disclose the underlying mechanisms of action, the effect of Rhodiola crenulata root (RCR) on insulin resistance was investigated.

Methods

Male Sprague-Dawley rats were treated with liquid fructose in their drinking water over 18 weeks. The extract of RCR was co-administered (once daily by oral gavage) during the last 5 weeks. The indexes of lipid and glucose homeostasis were determined enzymatically and/or by ELISA. Gene expression was analyzed by Real-time PCR, Western blot and/or confocal immunofluorescence.

Results

RCR extract (50 mg/kg) suppressed fructose-induced hyperinsulinemia and the increases in the homeostasis model assessment of insulin resistance index and the adipose tissue insulin resistance index in rats. Additionally, this treatment had a trend to restore the ratios of glucose to insulin and non-esterified fatty acids (NEFA) to insulin. Mechanistically, RCR suppressed fructose-induced acceleration of the clearance of plasma NEFA during oral glucose tolerance test (OGTT), and decreased triglyceride content and Oil Red O staining area in the gastrocnemius. Furthermore, RCR restored fructose-induced sarcolemmal overexpression and intracellular less distribution of fatty acid translocase/CD36 that contributes to etiology of insulin resistance by facilitating fatty acid uptake.

Conclusion

These results suggest that RCR ameliorates insulin resistance in fructose-fed rats by modulating sarcolemmal and intracellular CD36 redistribution in the skeletal muscle. Our findings may provide a better understanding of the traditional use of Rhodila species.

Peer Review reports

Background

Insulin resistance is the thread that runs through many chronic afflictions of modern times–obesity, cardiovascular disease, and most conspicuously, type 2 diabetes [1]. Recently, a large body of evidence has suggested that depression and fatigue are linked to some metabolic disorders, such as obesity, insulin resistance, diabetes and liver disease [2–9]. Depression may occur as a consequence of having diabetes. It has been suggested that insulin resistance is a part of the pathophysiology of affective disorders, and that improvement of insulin resistance may reduce the severity of depressive symptoms [10, 11]. Treatments of type 2 diabetic patients with insulin sensitizers rosiglitazone and pioglitazone improve not only metabolic derangements, but also affective disorders [10, 12–14]. On the other hand, depression may also be a risk factor for the onset of type 2 diabetes; depressed adults have a 37 % increased risk of developing type 2 diabetes mellitus [15]. Similarly, endocrine dysfunction is a common etiology of fatigue. Chronic fatigue has been associated with obesity and its metabolic complications [16]. Therefore, these research findings suggest that amelioration of insulin resistance may result in improvement of depression and fatigue, and conversely, effective prevention or treatment of depression may reduce insulin resistance-associated health consequences.

The roots of the alpine plant genus Rhodiola (Crassulaceae) have been traditional medicines in Eastern Europe and Asia. Rhodila species are used as tonics and stimulants to increase physical endurance, work productivity and longevity, and to enhance energy levels [17, 18]. Thus, Rhodila species are used to treat patients with asthenia [17, 18]. It has been demonstrated that treatment of type 2 diabetic patients with Rhodiola crenulata tea for 12–24 months significantly lowered blood glucose concentration, accompanied by improvement of dysfunctions of liver and kidneys [19]. Rhodioa rosea, another species of Rhodiola, has been reported to show synergistic effects with losartan, an angiotensin II type 1 receptor blocker, on hyperglycemia and hyperlipidemia in patients with early diabetic nephropathy [20]. We have also demonstrated that treatment with RCR ameliorates derangements of glucose and lipid metabolism in Zucker diabetic fatty rats [21]. Salidroside, one of the prominent active components contained in Rhodila species, ameliorates insulin resistance in db/db mice [22]. In addition, Rhodila species have also been used to treat fatigue and depression [17, 18]. Based on the research findings, we hypothesized that the underlying mechanisms of action of Rhodila species for their traditional use were associated with improvement of insulin resistance.

Strong evidence suggests that chronically high consumption of fructose in rodents leads to dyslipidemia, fatty liver, insulin resistance, obesity, and type 2 diabetes mellitus [23]. During obesity an increase in the circulating fatty acids released from the abdominal fat depots leads to increased uptake by non-adipose tissues, such as skeletal muscle, thereby inhibiting glucose oxidation and reducing insulin sensitivity [24]. Thus, abnormal fatty acid metabolism, especially in skeletal muscle, is linked to insulin resistance [25]. Membrane uptake of long-chain fatty acids is the first step in cellular fatty acid utilization and a point of metabolic regulation. Fatty acid translocase/CD36, a multi-functional glycoprotein, facilitates a major fraction of fatty acid uptake by some key tissues, such as skeletal muscle, and plays an important role in membrane transport and utilization of long-chain fatty acids [26]. CD36 is involved in a number of metabolic pathways, and contributes to development of insulin resistance and the metabolic syndrome [25, 26]. Research has shown that sugar-sweetened nonalcoholic beverages, such as soft drinks, appear as the major source of fructose for all classes of age considered, except for children younger than 6 years and adults older than 50 years [23]. To better understand the traditional application of Rhodila species, the present study investigated the effect of an extract of RCR on insulin resistance and the possible involvement of CD36 in the underlying mechanisms of action in liquid fructose-fed rats.

Methods

Preparation and identification of an aqueous-ethanolic extract of RCR

RCR was collected in Tibet, China. A voucher specimen (No: PS0183) was deposited in Pharmafood Institute, Kyoto, Japan. Dried RCR was identified botanically by Professor Johji Yamahara, who is an expert in taxonomy. The aqueous-ethanolic extract used in the present study was prepared. Briefly, dried RCR materials were ground into crude powder, immersed in 7 volumes of 50 % ethanol (50 °C) with intermittent shaking for 5 h, and filtrated. The residue was extracted for additional 2 times using the same method. The combined filtrate was evaporated under reduced pressure below 45 °C. The yield of the extract was 15 %. The extract was quantified by the HPLC method previously described [21] to contain 2.5 % salidroside, one of prominent active components contained in Rhodila species. HPLC fingerprints of RCR extract and salidroside standard (inset) at 275 nm are shown in Fig. 1.

Fig. 1
figure 1

HPLC fingerprints of the aqueous-ethanolic extract of Rhodiola crenulata root (RCR) and salidroside standard (inset) at 275 nm

Full size image

Animals, diet and experimental protocol

All experimental procedures were carried out in accordance with the internationally accepted principles for laboratory animal use and care, and approved by the Animal Ethics Committee, Chongqing Medical University, China.

Male Sprague–Dawley rats weighing 210–230 g and the standard chow were supplied by the laboratory animal center, Chongqing Medical University, China. Rats were housed in a temperature controlled facility (21 ± 1 °C, 55 ± 5 % relative humidity) with a 12-h light/dark cycle. Animals were allowed free access to water and the standard chow for at least 1 week prior to starting the experiments.

Fructose in drinking water used for the present study, has been described previously [27–31]. Thirty-three rats were divided initially into 2 groups: water control free access to water (n = 6), and fructose group free access to 10 % fructose solution (w/v, preparation every day) (n = 27). This fructose group was further divided into the following 3 groups (n = 9) 13 weeks after study commencement and had continued free access to 10 % fructose solution until the end of week 18: fructose control, fructose RCR 10 mg/kg and fructose RCR 50 mg/kg. Animals in RCR-treated groups were administered RCR extract at the dosages of 10 and 50 mg/kg (suspended in 5 % Gum Arabic solution, gavage once daily), respectively. The rats in the corresponding water- and fructose-control groups received vehicle (5 % Gum Arabic) alone. All rats had free access to the standard chow. To avoid stress and increase monitoring accuracy of fructose and chow intakes, only 2–3 rats were housed in a cage at any given time. The consumed chow and fructose solution were measured daily and the intake of fructose was calculated. At the end of week 17, blood samples were collected by retroorbital venous puncture under ether anesthesia under overnight-fasted condition. Here, the plasma concentrations of glucose (kit from Kexin Institute of Biotechnology, Shanghai, China), insulin (kit from Morinaga Biochemical Industries, Tokyo, Japan), triglyceride (Triglyceride-E kit, Wako, Osaka, Japan), non-esterified fatty acids (NEFA) (NEFA-C kit, Wako, Osaka, Japan) and total cholesterol (kit from Kexin Institute of Biotechnology, Shanghai, China) were determined using enzymatic methods or by ELISA. Immediately followed, OGTT was performed. Animals were weighed and euthanized after being fasted overnight at the end of week 18. Epididymal fat and gastrocnemius (right) were collected. Segments of gastrocnemius were individually snap frozen in liquid nitrogen and stored at -80 °C for subsequent determination of the content of triglyceride and/or gene expression.

OGTT

After being fasted overnight, all rats received a glucose solution (2 g/kg in 5 ml) by the oral gavage. Blood samples were collected prior to and 20, 60 and 120 min after administration of glucose solution. Plasma concentrations of glucose and NEFA were determined. The homeostasis model assessment of insulin resistance (HOMA-IR) index {[fasted insulin (μIU/mL) × fasted glucose (mM)]/22.5} and the Adipo-IR index [Adipo-IR index = fasted insulin (mmol/L) × fasted NEFA (pmol/L)] were calculated [32, 33]. The clearance of plasma NEFA was calculated as the following formula: the concentration under fasted condition (0 min) – the concentration at the time-point (20, 60 or 120 min) after glucose administration. The area under the curve (AUC) of plasma concentrations and/or clearances of glucose and NEFA was calculated, respectively.

Determination of triglyceride content in skeletal muscle

Triglyceride content in the gastrocnemius was determined as described previously [28, 31]. Briefly, 100 mg of tissue was homogenized and extracted with 2 mL of isopropanol. After centrifugation (625 × g), the triglyceride content in supernatant was determined enzymatically (Wako, Osaka, Japan).

Measurement of fatty droplet accumulation in skeletal muscle

A portion of gastrocnemius was frozen, and six-micron sections were cut and stained with Oil Red O for examination of fatty droplet accumulation (BX-51, Olympus Corporation, Tokyo, Japan). Forty fields in individual section were randomly selected, and the Oil Red O-stained and total fiber areas were measured using an ImageJ 1.43 analyzing system. The ratio of the Oil Red O-stained area to the total tissue area was calculated (%).

Real time PCR

Real time PCR was performed as described previously [31]. Total RNA was isolated from gastrocnemius of individual rats using TRIzol (Takara, Dalian, China). cDNA was synthesized using M-MLV RTase cDNA Synthesis Kit (Takara, Dalian, China) according to the manufacturer’s instructions. Real time PCR was performed with the CFX 96 Real Time PCR Detection System (Biorad Laboratories Inc, Hercules, CA, USA) using the SYBR® Premix Ex Taq™ II (Takara, Dalian, China). The sequences of primers are shown in Table 1. The gene expression from each sample was analysed in duplicates and normalized against the internal control gene β-actin. Levels in control rats were arbitrarily assigned a value of 1.

Table 1 Primer sequences for real time PCR assays
Full size table

Western blot

Western blot was performed basically as described previously [28, 31]. Total protein was prepared from gastrocnemius using the T-PER tissue protein extraction reagent kits (Pierce Biotechnology, Rockford, IL, USA), according to the manufacturer’s instructions. Protein concentration was determined using the Bradford method (Bio Rad Laboratories, Hercules, CA, USA) using bovine serum albumin as a standard. Protein (30 μg) was subjected to SDS-PAGE analysis on a 10 % gel, then electrotransferred onto Polyvinylidene Fluoride Membrane (Amersham, Buckinghamshire, UK). CD36 (dilution 1:1000, Abcam, Cambridge, Massachusetts, USA) was detected with a rabbit polyclonal antibody. Detection of signal was performed using the ECL Western blot detection kit (Pierce Biotechnology, Rockford, IL, USA) with anti-rabbit horseradish peroxidase-conjugated IgG (dilution 1:5,000, Santa Cruz Biotechnology, Santa Cruz, CA, USA) as second antibody, respectively. Polyclonal rabbit β-actin antibody (Cell Signaling Technologies, Beverly, MA, USA) was used as loading control to normalize the signal obtained for CD36 protein. The immunoreactive bands were visualized by autoradiography and the density was evaluated using ImageJ 1.43. Levels in control rats were arbitrarily assigned a value of 1.

Immunofluorescence staining

To examine CD36 distribution in rat skeletal muscle fibers, cryosections were immunofluorescently labeled and analyzed by confocal microscopy. Transverse cryosections from gastrocnemius were transferred to glass slides, and allowed to dry at room temperature. The sections were blocked with normal goat serum for 30 min and incubated with rabbit polyclonal anti-CD36 antibody (dilution 1:200, Abcam, Cambridge, Massachusetts, USA) in blocking buffer at 4 °C overnight. Sections were rinsed with PBS three times and incubated with CY3-labeled goat anti-rabbit IgG as secondary antibody in blocking buffer for 30 min. Sections were rinsed with PBS three times again and nuclei were counterstained with DAPI (Molecular Probes/Invitrogen Life Technologies, Carlsbad, CA, USA). Finally, sections were mounted and analyzed as described previously [34]. Images were collected with confocal microscope (A1 + R confocal microscope, Nikon Corporation, Tokyo, Japan). Imaging settings were set so that no signal was detected in the respective negative controls and a low fraction of pixels showed saturation intensity values when imaging the stained samples.

Semi-quantification of CD36 expression [34]

On transverse cryosections from gastrocnemius stained with anti-CD36, skeletal muscle fiber was rated 1, 2 or 3 based on the intensity of the sarcolemmal CD36 fluorescent signal by a person who was blinded. To check interobserver variability, another blinded person also rated the intensity of the fluorescence signal with similar results. In each sample, ~100 fibers were rated. The percentage of fibers rated 1, 2, and 3 each sample was calculated respectively.

Data analysis

All results are expressed as mean ± SEM. Data were analyzed by ANOVA using StatView, and followed by Student-Newman-Keuls testing to locate the differences between groups. P < 0.05 was considered to be statistically significant.

Results

Effects on intakes of fructose and chow, body weight increase and epididymal fat weight in rats

Fructose control and fructose RCR groups consumed similar amount of fructose during the last five weeks (Fig. 2a). Intake of fructose decreased chow intake in the same manner in both fructose control and fructose RCR groups (Fig. 2b).

Fig. 2
figure 2

Intakes of fructose (a) and laboratory chow (b), body weight increase (c), and epididymal fat weight (d) in rats. The fructose controls (Rhodiola 0 mg/kg) and fructose Rhodiola (50 mg/kg) group had free access to 10 % fructose in their drinking water over 18 weeks. The water controls (Rhodiola 0 mg/kg) had free access to a tap water. Rhodiola (50 mg/kg) was administered by gavage daily during the last 5 weeks. The water and fructose controls received vehicle (5 % Gum Arabic) alone. Data are means ± SEM (n = 6-9 each group). * P < 0.05

Full size image

There was no significant difference in body weight increase between water control and fructose control or fructose RCR groups (Fig. 2c). However, long term fructose consumption increased epididymal fat weight, whereas treatment with RCR did not affect epididymal fat weight in fructose-fed rats (Fig. 2d).

Effects on glucose metabolism in rats

Although fructose feeding did not alter plasma glucose concentration at the baseline (under fasted condition) (Fig. 3a), it had a trend to increase glucose concentrations during OGTT (Fig. 3e, f). Strikingly, fructose consumption increased basal plasma insulin concentration and the HOMA-IR index by three folds (Fig. 3b, c). Furthermore, fructose feeding decreased the ratio of glucose to insulin (Fig. 3d). RCR treatment did not affect plasma glucose concentrations both under fasted condition (Fig. 3a) and during OGTT (Fig. 3e, f) in fructose-fed rats. However, RCR dose-dependently suppressed the increases in basal plasma insulin concentration and the HOMA-IR index (Fig. 3b, c), and had a trend to restore the decreased ratio of glucose to insulin (Fig. 3d).

Fig. 3
figure 3

Plasma glucose (a) and insulin (b) concentrations under fasting condition, HOMA-IR index (c), the ratio of glucose to insulin (d), plasma glucose concentrations and the AUC of plasma glucose concentrations (e and f) during OGTT in rats. The fructose controls (Rhodiola 0 mg/kg) and fructose Rhodiola (50 mg/kg) group had free access to 10 % fructose in their drinking water over 18 weeks. The water controls (Rhodiola 0 mg/kg) had free access to a tap water. Rhodiola (50 mg/kg) was administered by gavage daily during the last 5 weeks. The water and fructose controls received vehicle (5 % Gum Arabic) alone. Data are means ± SEM (n = 6-9 each group). * P < 0.05

Full size image

Effects on lipid metabolism in rats

Fructose feeding did not induce a significant change in plasma total cholesterol concentration (Fig. 4a), but increased plasma triglyceride and NEFA concentrations at the baseline (Fig. 4b, c), and the Adipo-IR index (Fig. 4d). Fructose feeding decreased the ratio of NEFA to insulin (Fig. 4e). RCR treatment minimally affected the fasting plasma concentration of total cholesterol, triglyceride and NEFA (Fig. 4a-c), whereas RCR (50 mg/kg) suppressed the increased Adipo-IR index (Fig. 4d) and had a trend to restore the decreased NEFA to insulin ratio (Fig. 4e).

Fig. 4
figure 4

Fasting plasma concentrations of total cholesterol (a), triglyceride (b) and NEFA (c), Adipo-IR index (d) and the ratio of NEFA to insulin (e) in rats. The fructose controls (Rhodiola 0 mg/kg) and fructose Rhodiola (50 mg/kg) group had free access to 10 % fructose in their drinking water over 18 weeks. The water controls (Rhodiola 0 mg/kg) had free access to a tap water. Rhodiola (50 mg/kg) was administered by gavage daily during the last 5 weeks. The water and fructose controls received vehicle (5 % Gum Arabic) alone. Data are means ± SEM (n = 6-9 each group). * P < 0.05

Full size image

Oral glucose administration decreased plasma NEFA concentration in all groups; there was no significant difference in plasma NEFA concentration (Fig. 5a) and the AUC of plasma NEFA concentration (Fig. 5b) during OGTT. However, the clearance of plasma NEFA (Fig. 5c) and the AUC of plasma NEFA clearance (Fig. 5d) after oral glucose administration were increased in fructose controls compared to water controls. RCR treatment did not affect plasma NEFA concentration (Fig. 5a) and the AUC of plasma NEFA concentration (Fig. 5b), but dose-dependently decreased the clearance of plasma NEFA (Fig. 5c) and the AUC of plasma NEFA clearance (Fig. 5d) in fructose-fed rats.

Fig. 5
figure 5

Plasma NEFA concentrations (a), the AUC of plasma NEFA concentrations (b), plasma NEFA clearance (c), and the AUC of plasma NEFA clearance (d) during OGTT in rats. The fructose controls (Rhodiola 0 mg/kg) and fructose Rhodiola (50 mg/kg) group had free access to 10 % fructose in their drinking water over 18 weeks. The water controls (Rhodiola 0 mg/kg) had free access to a tap water. Rhodiola (50 mg/kg) was administered by gavage daily during the last 5 weeks. The water and fructose controls received vehicle (5 % Gum Arabic) alone. Data are means ± SEM (n = 6-9 each group). * P < 0.05

Full size image

Long term fructose consumption also increased triglyceride content (Fig. 6a) and Oil Red O stained area in the gastrocnemius, which was attenuated by RCR treatment (50 mg/kg) (Fig. 6d-g).

Fig. 6
figure 6

Triglyceride content in the gastrocnemius (a), skeletal muscular CD36 mRNA (b) and protein (c) expression, Oil Red O staining area (d-g) in rats. The fructose controls (Rhodiola 0 mg/kg) and fructose Rhodiola (50 mg/kg) group had free access to 10 % fructose in their drinking water over 18 weeks. The water controls (Rhodiola 0 mg/kg) had free access to a tap water. Rhodiola (50 mg/kg) was administered by gavage daily during the last 5 weeks. The water and fructose controls received vehicle (5 % Gum Arabic) alone. mRNA was determined by Real-time PCR and normalized to β-actin, while protein expression was analyzed by Western blot and normalized to β-actin. Expression in water control was arbitrarily assigned a value of 1. Data are means ± SEM (n = 6-9 each group)

Full size image

Gene/protein expression profile in rats

As treatment with RCR at 10 mg/kg showed less effect on all parameters observed, gene expression analysis and comparisons were restricted in water control, fructose control and fructose RCR 50 mg/kg groups. By Real-time PCR and Western blot, fructose feeding did not significantly affect total muscular expression of CD36 mRNA and protein; RCR treatment was without effect in fructose-fed rats (Fig. 6b, c).

Fructose feeding decreased the percentage of fibers expressing sarcolemmal CD36 weakly (rating 1), but increased the percentage of fibers expressing sarcolemmal CD36 abundantly (rating 3), whereas it did not alter the percentage of fibers rated 2 (Fig. 7a-f). RCR treatment completely reversed fructose-induced change in sarcolemmal CD36 expression (Fig. 7a-f).

Fig. 7
figure 7

Sarcolemmal CD36 expression in skeletal muscle fibers of rats. The fructose controls (Rhodiola 0 mg/kg) and fructose Rhodiola (50 mg/kg) group had free access to 10 % fructose in their drinking water over 18 weeks. The water controls (Rhodiola 0 mg/kg) had free access to a tap water. Rhodiola (50 mg/kg) was administered by gavage daily during the last 5 weeks. The water and fructose controls received vehicle (5 % Gum Arabic) alone. Transverse cryosections from gastrocnemius were fixed and stained with anti-CD36 rabbit polyclonal antibody. Muscle fiber was rated as 1, 2 or 3 based on the intensity of the sarcolemmal CD36 fluorescent signal. ~100 fibers were rated each rat. The percentage of different group fibers given each rating was calculated. Data are means ± SEM (n = 6 each group). * P < 0.05

Full size image

Also in the gastrocnemius, fructose feeding did not alter mRNA expression of peroxisome proliferator-activated receptor (PPAR)-γ (Fig. 8a), adiponectin (Fig. 8b), acyl-coenzyme A:diacylglycerol acyltransferase (DGAT)-1 (Fig. 8c) and DGAT-2 (Fig. 8d). RCR treatment showed minimal effect on expression of these genes (Fig. 8a-d).

Fig. 8
figure 8

Skeletal muscular mRNA expression of peroxisome proliferator-activated receptor (PPAR)-γ (a), adiponectin (b), acyl-coenzyme A:diacylglycerol acyltransferase (DGAT)-1 (c) and DGAT-2 (d) in rats. The fructose controls (Rhodiola 0 mg/kg) and fructose Rhodiola (50 mg/kg) group had free access to 10 % fructose in their drinking water over 18 weeks. The water controls (Rhodiola 0 mg/kg) had free access to a tap water. Rhodiola (50 mg/kg) was administered by gavage daily during the last 5 weeks. The water and fructose controls received vehicle (5 % Gum Arabic) alone. mRNA was determined by Real-time PCR and normalized to β-actin. Expression in water control was arbitrarily assigned a value of 1. Data are means ± SEM (n = 6-9 each group)

Full size image

Discussion

The present study clearly demonstrated that treatment with RCR extract suppressed fructose-induced hyperinsulinemia, and increases in the HOMA-IR index and the Adipo-IR index in rats. In addition, the treatment had a trend to restore the ratios of glucose to insulin and NEFA to insulin. These results suggest that RCR extract treatment ameliorates fructose consumption-induced insulin resistance in rats.

Skeletal muscle is regarded as the major site of insulin resistance in obesity and type 2 diabetes [35]. Mounting evidence indicates that insulin resistance is highly associated with excessive intramyocellular triglyceride accumulation [36–38]. High fructose diets are known to cause insulin resistance [39] and triglyceride accumulation [40] in the skeletal muscle of rodents. In healthy subjects with and without a family history of type 2 diabetes, fructose overconsumption also increases lipid accumulation in skeletal muscle [41]. Rhodiola species enhance energy levels to increase physical endurance and work productivity [17, 18]. Salidroside, one of the major active components found in RCR, has been demonstrated to stimulate glucose uptake in skeletal muscle cells [42]. These findings suggest that skeletal muscle is one of the major target sites of Rhodila species. In the present study, triglyceride accumulation and Oil Red O-stained area in rat skeletal muscle were increased after chronic fructose consumption. Treatment with RCR extract ameliorated the excessive lipid accumulation in fructose-fed rats.

The increased lipid deposition in muscle is secondary to increased fatty acid transport in obese Zucker rats [43], high fat-fed rats [44] and obese, insulin-resistant humans [45]. The increased concentration of blood glucose after oral glucose administration during OGTT strongly stimulates the β-cells to secrete and release insulin, subsequently inhibits adipose lipolysis. Release of fatty acids from adipose tissue under fasted condition is shifted to uptake of fatty acids by key tissues, such as skeletal muscle, after oral glucose administration. Thus, the clearance of plasma fatty acids during OGTT reflects the status of uptake of fatty acids by the key tissues. In the present study, fructose feeding increased clearance of plasma NEFA during OGTT. This acceleration was attenuated after RCR extract treatment. These results suggest that RCR extract treatment may decrease fructose-induced excessive triglyceride accumulation in the skeletal muscle by inhibiting the increased uptake of fatty acids by skeletal muscle.

The fatty acid transport from blood circulation to skeletal muscle involves the translocation of CD36, but not plasma membrane fatty acid–binding protein, from intracellular membrane compartments to the sarcolemma [46]. In muscle from diabetic rodents and humans, more CD36 is recruited to the plasma membrane, leading to persistent enhancement of fatty acid uptake, thereby possibly contributing to the impairment of insulin signaling and glucose utilization [24]. Fructose feeding has been demonstrated to increase CD36 expression in the sarcolemma, but not in whole tissue homogenates from the skeletal muscle, in rats, suggesting a fructose-induced redistribution of this protein associated with fatty acid uptake across the plasma membrane [47]. In the present study, fructose feeding did not alter CD36 expression at the mRNA and protein level in whole skeletal muscle. However, the semi-quantitative assessment by confocal immunofluorescence revealed that sarcolemmal CD36 was overexpressed, while intracellular CD36 distribution in the gastrocnemius was downregulated after fructose feeding. The fructose-induced redistribution of CD36 was restored by RCR extract treatment. Taken together, our findings suggest that RCR extract treatment-elicited insulin-sensitizing action is associated with modulation of CD36 redistribution in the skeletal muscle.

CD36 is a well-known target of PPAR-γ ligands [48]. PPAR-γ agonists stimulate the production of adiponectin, which promotes fatty acid oxidation and insulin sensitivity in muscle and liver [49]. DGATs are the enzymes that catalyze the final step and rate-limiting reaction in triglyceride synthesis. Both DGAT-1 and DGAT-2 in skeletal muscle play a specific role in regulating insulin sensitivity [50]. In the present study, however, fructose feeding did not alter muscular expression of PPAR-γ, adiponectin, DGAT-1 and DGAT-2. RCR extract treatment also showed minimal effect on expression of these genes in fructose-fed rats. Thus, these results do not support an association of modulation of CD36 by RCR extract treatment with muscular PPAR-γ and a link of decreased lipid content to triglyceride synthesis in the skeletal muscle.

Zheng et al. have reported that salidroside ameliorates insulin resistance in db/db mice [22]. The authors also have demonstrated that in vitro salidroside activates the AMP-dependent protein kinase-mediated pathway in the mitochondria of hepatocytes. CD36 and potentially other lipid binding proteins have been demonstrated to function as dynamic regulators of fatty acid transport by relocating from intracellular compartments to the plasma membrane in skeletal muscle in response to pharmacological activation of the AMP-dependent protein kinase by 5-aminoimidazole-4-carboxamide ribonucleoside [51]. This finding suggests a link of CD36 to the AMP-dependent protein kinase. Thus, it needs to further investigate whether modulation of sarcolemmal and intracellular CD36 redistribution in the skeletal muscle by Rhodiola crenulate root extract is associated with activation of the muscular AMP-dependent protein kinase-mediated pathway pathway.

Although CD36 is also particularly abundant in adipose tissue, it is still unclear whether CD36 function in adipocytes influences ectopic fat distribution and the pathogenesis of insulin resistance in muscle and liver [25]. In the present study, RCR extract treatment did not affect body weight increase and epididymal fat weight in fructose-fed rats. However, this study still cannot exclude the role of adipose CD36 in RCR extract treatment-elicited amelioration of insulin resistance. On the other hand, we have recently demonstrated that mangiferin, a xanthone glucoside, also mitigates fructose-induced insulin resistance via modulation of CD36 redistribution in the skeletal muscle of Wistar-Kyoto rats [52]. It would be interesting to further investigate whether RCR extract, salidroside, mangiferin and other herb-derived insulin sensitizers share the similar mechanisms to modulate CD36 in ameliorating insulin resistance.

Conclusions

In conclusion, our present results demonstrate that treatment with RCR extract ameliorates insulin resistance by modulating sarcolemmal and intracellular redistribution in the skeletal muscle of fructose-fed rats. Our findings may provide a better understanding of the traditional use of Rhodila species.

Abbreviations

Adipo-IR, adipose tissue insulin resistance; AUC, the area under the curve; DGAT, acyl-coenzyme A:diacylglycerol acyltransferase; HOMA-IR, the homeostasis model assessment of insulin resistance; NEFA, non-esterified fatty acids; PPAR, peroxisome proliferator-activated receptor; RCR, Rhodiola crenulata root.

References

  1. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev. 2008;29:777–822.

    Article  CAS  PubMed  Google Scholar 

  2. Vgontzas AN, Kales A. Sleep and its disorders. Annu Rev Med. 1999;50:387–400.

    Article  CAS  PubMed  Google Scholar 

  3. McCaffery JM, Niaura R, Todaro JF, Swan GE, Carmelli D. Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart, Lung, and Blood Institute twin study. Psychosom Med. 2003;65:490–7.

    Article  PubMed  Google Scholar 

  4. Hedley A, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291:2847–50.

    Article  CAS  PubMed  Google Scholar 

  5. Skilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry. 2007;62:1251–7.

    Article  CAS  PubMed  Google Scholar 

  6. Takeuchi T, Nakao M, Nomura K, Inoue M, Tsurugano S, Shinozaki Y, et al. Association of the metabolic syndrome with depression and anxiety in Japanese men: a 1-year cohort study. Diabetes-Metab Res. 2009;25:762–7.

    Article  Google Scholar 

  7. Fritschi C, Quinn L. Fatigue in patients with diabetes: a review. J Psychosom Res. 2010;69:33–41.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Katon W. Depression and diabetes: unhealthy bedfellows. Depress Anxiety. 2010;27:323–6.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Labad J, Price JF, Strachan MW, Fowkes FG, Ding J, Deary IJ, et al. Edinburgh Type 2 Diabetes Study I, Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia. 2010;53:467–71.

    Article  CAS  PubMed  Google Scholar 

  10. Rasgon N, Jarvik GP, Jarvik L. Affective disorders and Alzheimer disease: a missing-link hypothesis. Am J Geriatr Psychiatry. 2001;9:444–5.

    Article  CAS  PubMed  Google Scholar 

  11. Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer’s disease: review and hypothesis. J Gerontol A Biol Sci Med Sci. 2004;59:178–83.

    Article  PubMed  Google Scholar 

  12. Kemp DE, Ismail-Beigi F, Calabrese JR. Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome. Am J Psychiatry. 2009;166:619.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wagner J, Allen NA, Swalley LM, Melkus GD, Whittemore R. Depression, depression treatment, and insulin sensitivity in adults at risk for type 2 diabetes. Diabetes Res Clin Pr. 2009;86:96–103.

    Article  CAS  Google Scholar 

  14. Kemp DE, Ismail-Beigi F, Ganocy SJ, Conroy C, Gao K, Obral S, et al. Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity. J Affect Disord. 2012;136:1164–73.

    Article  CAS  PubMed  Google Scholar 

  15. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis Diabetologia. 2006;49:837–45.

    CAS  PubMed  Google Scholar 

  16. Kaltsas G, Vgontzas A, Chrousos G. Fatigue, endocrinopathies, and metabolic disorders. PM and R. 2010;2:393–8.

    Article  PubMed  Google Scholar 

  17. Kelly GS. Rhodiola rosea: a possible plant adaptogen. Altern Med Rev. 2001;6:293–302.

    CAS  PubMed  Google Scholar 

  18. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17:481–93.

    Article  CAS  PubMed  Google Scholar 

  19. Fan Y, Tan R, Jiang L. Evaluation of treatment of 27 cases of type 2 diabetic patients with Rhodiola crenulata tea. Chinese Journal of Modern Drug Application. 2007;1:10–1.

    Google Scholar 

  20. Liang M, Zhang Y, Xiang W. Clinical observation on therapeutic effects of combined use of Rhodioa rosea and losartan in treating diabetic nephropathy. Chinese Journal of Integrated Traditional and Western Nephrology. 2008;9:694–7.

    Google Scholar 

  21. Wang J, Rong X, Li W, Yang Y, Yamahara J, Li Y. Rhodiola crenulata root ameliorates derangements of glucose and lipid metabolism in a rat model of the metabolic syndrome and type 2 diabetes. J Ethnopharmacol. 2012;142:782–8.

    Article  CAS  PubMed  Google Scholar 

  22. Zheng T, Yang X, Wu D, Xing S, Bian F, Li W, et al. Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway. Br J Pharmacol. 2015;172:3284–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Tappy L, Le KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90:23–46.

    Article  CAS  PubMed  Google Scholar 

  24. Schwenk RW, Luiken JJ, Bonen A, Glatz JF. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc Res. 2008;79:249–58.

    Article  CAS  PubMed  Google Scholar 

  25. Su X, Abumrad NA. Cellular fatty acid uptake: a pathway under construction. Trends Endocrin Met. 2009;20:72–7.

    Article  CAS  Google Scholar 

  26. Love-Gregory L, Abumrad NA. CD36 genetics and the metabolic complications of obesity. Curr Opin Clin Nutr Metab Care. 2011;14:527–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Gao H, Guan T, Li C, Zuo G, Yamahara J, Wang J, et al. Treatment with ginger ameliorates fructose-induced Fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway. Evid-Based Compl Alt. 2012;2012:570948.

    Google Scholar 

  28. Liu C, Li Y, Zuo G, Xu W, Gao H, Yang Y, et al. Oleanolic Acid diminishes liquid fructose-induced Fatty liver in rats: role of modulation of hepatic sterol regulatory element-binding protein-1c-mediated expression of genes responsible for de novo Fatty Acid synthesis. Evid-Based Compl Alt. 2013;2013:534084.

    Google Scholar 

  29. Wang J, Gao H, Ke D, Zuo G, Yang Y, Yamahara J, et al. Improvement of liquid fructose-induced adipose tissue insulin resistance by ginger treatment in rats is associated with suppression of adipose macrophage-related proinflammatory cytokines. Evid-Based Compl Alt. 2013;2013:590376.

    Google Scholar 

  30. Li Y, Wang J, Gu T, Yamahara J, Li Y. Oleanolic acid supplement attenuates liquid fructose-induced adipose tissue insulin resistance through the insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt signaling pathway in rats. Toxicol Appl Pharmacol. 2014;277(2):155–63.

    Article  CAS  PubMed  Google Scholar 

  31. Xing X, Li D, Chen D, Zhou L, Chonan R, Yamahara J, et al. Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A: diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats: a link to amelioration of fatty liver. Toxicol Appl Pharm. 2014;280(2):207–15.

    Article  CAS  Google Scholar 

  32. Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, et al. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology. 2009;50:1087–93.

    Article  CAS  PubMed  Google Scholar 

  33. Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology. 2010;52:774–88.

    Article  PubMed  Google Scholar 

  34. Kelley DE, Goodpaster BH, Storlien L. Muscle triglyceride and insulin resistance. Annu Rev Nutr. 2002;22:325–46.

    Article  CAS  PubMed  Google Scholar 

  35. Vistisen B, Roepstorff K, Roepstorff C, Bonen A, van Deurs B, et al. Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers. J Lipid Res. 2004;45:603–9.

    Article  CAS  PubMed  Google Scholar 

  36. Machann J, Haring H, Schick F, Stumvoll M. Intramyocellular lipids and insulin resistance. Diabetes Obes Metab. 2004;6:239–48.

    Article  CAS  PubMed  Google Scholar 

  37. Stannard SR, Johnson NA. Insulin resistance and elevated triglyceride in muscle: more important for survival than “thrifty” genes? J Physiol. 2004;554:595–607.

    Article  CAS  PubMed  Google Scholar 

  38. Kuhlmann J, Neumann-Haefelin C, Belz U, Kramer W, Juretschke HP, Herling AW. Correlation between insulin resistance and intramyocellular lipid levels in rats. Magn Reson Med. 2005;53:1275–82.

    Article  CAS  PubMed  Google Scholar 

  39. Storlien LH, Pan DA, Kusunoki M, Cooney GJ. Effects of benfluorex on in vivo patterns of insulin resistance induced by diets rich in fat or fructose. Diabetes Metab Rev. 1993;9 Suppl 1:65S–72S.

    Article  CAS  PubMed  Google Scholar 

  40. Song GY, Ren LP, Chen SC, Wang C, Liu N, Wei LM, et al. Similar changes in muscle lipid metabolism are induced by chronic high-fructose feeding and high-fat feeding in C57BL/J6 mice. Clin Exp Pharmacol Physiol. 2012;39:1011–8.

    Article  CAS  PubMed  Google Scholar 

  41. Le KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009;89:1760–5.

    Article  CAS  PubMed  Google Scholar 

  42. Li HB, Ge YK, Zheng XX, Zhang L. Salidroside stimulated glucose uptake in skeletal muscle cells by activating AMP-activated protein kinase. Eur J Pharmacol. 2008;588:165–9.

    Article  CAS  PubMed  Google Scholar 

  43. Coort SL, Bonen A, van der Vusse GJ, Glatz JF, Luiken JJ. Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters. Mol Cell Biochem. 2007;299:5–18.

    Article  CAS  PubMed  Google Scholar 

  44. Ouwens DM, Diamant M, Fodor M, Habets DD, Pelsers MM, El Hasnaoui M, et al. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia. 2007;50:1938–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Bonen A, Parolin ML, Steinberg GR, Calles-Escandon J, Tandon NN, Glatz JF, et al. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 2004;18:1144–6.

    CAS  PubMed  Google Scholar 

  46. Luiken JJ, Arumugam Y, Dyck DJ, Bell RC, Pelsers MM, Turcotte LP, et al. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J Biol Chem. 2001;276:40567–73.

    Article  CAS  PubMed  Google Scholar 

  47. Huynh M, Luiken JJ, Coumans W, Bell RC. Dietary fructose during the suckling period increases body weight and fatty acid uptake into skeletal muscle in adult rats. Obesity. 2008;16:1755–62.

    Article  CAS  PubMed  Google Scholar 

  48. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1998;93:241–52.

    Article  CAS  PubMed  Google Scholar 

  49. Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med. 2004;10:355–61.

    Article  CAS  PubMed  Google Scholar 

  50. Shi Y, Cheng D. Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism. Am J Physiol Endocrinol Metab. 2009;297:E10–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Jeppesen J, Albers P, Luiken JJ, Glatz JF, Kiens B. Contractions but not AICAR increase FABPpm content in rat muscle sarcolemma. Mol Cell Biochem. 2009;326:45–53.

    Article  CAS  PubMed  Google Scholar 

  52. Zhou L, Pan Y, Chonan R, Batey R, Yamahara J, Wang J, et al. Mitigation of insulin resistance by mangiferin in a rat model of fructose-induced metabolic syndrome is associated with modulation of CD36 redistribution in the skeletal muscle. J Pharmacol Exp Ther. 2016;356:74–84.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was financially supported by the National Natural Science Foundation of China, China (Grant No: 81374033), the Natural Science Foundation of Chongqing Medical University, China (Grant No: X12100), Chongqing Science and Technology Commission, China (Grant No: cstc2013jcyjA10051), and R&D Agency for Curative Natural Products (a Japanese government-registered non-profit organization), Kyoto, Japan.

Availability of data and materials

The datasets supporting the conclusions of this article are included within the article.

Authors’ contributions

TC performed the experiments, analyzed/interpreted data and drafted the manuscript. LY, DK, WC, GZ, LZ, JJ and JY analyzed/interpreted data. JW and YL contributed to the concept, designed experiments, analyzed/interpreted data and finalized the manuscript. All coauthors reviewed and discussed the paper. All authors read and approved the final manuscript.

Competing interest

The authors declare that they have no competing interest.

Consent for publication

Not applicable.

Ethics approval and consent to participate

All animal procedures in this study were complied with the standards for the care and use of experimental animals and approved by the Animal Ethics Committee of Chongqing Medical University, Chongqing, China (02/03/2015, No: 2015007).

Author information

Authors and Affiliations

  1. Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China

    Ting Chen & Liang Zhou

  2. The Laboratory of Traditional Chinese Medicine, Chongqing Medical University, Chongqing, 400016, China

    Ling Yao, Weiguo Cao, Yuhao Li & Jianwei Wang

  3. The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, China

    Dazhi Ke

  4. College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, China

    Guowei Zuo

  5. Endocrinology and Metabolism Group, Sydney Institute of Health Sciences/Sydney Institute of Traditional Chinese Medicine, Sydney, NSW 2000, Australia

    Jian Jiang & Yuhao Li

  6. Pharmafood Institute, Kyoto, 602-8136, Japan

    Johji Yamahara

Authors
  1. Ting Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ling Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dazhi Ke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Weiguo Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guowei Zuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Liang Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jian Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Johji Yamahara
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yuhao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jianwei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yuhao Li or Jianwei Wang.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, T., Yao, L., Ke, D. et al. Treatment with Rhodiola crenulata root extract ameliorates insulin resistance in fructose-fed rats by modulating sarcolemmal and intracellular fatty acid translocase/CD36 redistribution in skeletal muscle. BMC Complement Altern Med 16, 209 (2016). https://doi.org/10.1186/s12906-016-1176-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-016-1176-z

Keywords

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us